Zydus Lifesciences announced it is negotiating to acquire a majority stake in French medtech firm Amplitude Surgical for ...

India's Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical for 256.8 million ...

Zydus will focus on state-of-the-art manufacturing capabilities that will enable high quality solutions for patients with cutting-edge research and innovation, reports Financial Express.

Additionally, advancements in personalized medicine and innovative treatment approaches are ... Industries Ltd., Amneal ...

Personalized medicine is a therapeutic approach involving the use of an individual’s genetic and epigenetic information to tailor drug therapy or preventive care. We developed an endothelial ...

The Race and Medicine collection reflects NEJM’s commitment to understanding and combating racism as a public health and human rights crisis. Our commitment to antiracism includes efforts to ...

The discussions emphasised the evolving landscape of acute liver failure, sepsis in chronic liver disease, and post-transplant critical care The Tribune, now published from Chandigarh, started ...

Zydus Lifesciences has launched VaxiFlu-4, India’s first quadrivalent flu vaccine to offer better protection against influenza A and B strains. Experts stress the importance of vaccination and ...

Zydus Lifesciences on Wednesday said it is introducing a vaccine for protection against a new strain of influenza virus. The company is introducing the country’s first flu protection quadrivalent ...

Zydus Lifesciences on Wednesday (February 26, 2025) said it is introducing a vaccine for protection against new strain of influenza virus. “The company is introducing country’s first flu ...

Ahmedabad-based Zydus Lifesciences is set to launch the vaccine VaxiFlu-4 to combat a new strain of the influenza virus, as per the WHO-recommended composition of quadrivalent influenza virus ...

Zydus Cadila is all set to introduce VaxiFlu-4, a tetravalent inactivated influenza vaccine for seasonal flu, after the company received approvals from the Drug Controller General of India (DCGI), ...